WallStSmart

The Clorox Company (CLX)vsKenvue Inc. (KVUE)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Kenvue Inc. generates 124% more annual revenue ($15.12B vs $6.76B). CLX leads profitability with a 11.2% profit margin vs 9.7%. KVUE appears more attractively valued with a PEG of 1.49. KVUE earns a higher WallStSmart Score of 58/100 (C).

CLX

Buy

51

out of 100

Grade: C-

Growth: 2.0Profit: 7.5Value: 7.3Quality: 5.3
Piotroski: 5/9Altman Z: 2.08

KVUE

Buy

58

out of 100

Grade: C

Growth: 6.7Profit: 6.5Value: 8.7Quality: 4.5
Piotroski: 3/9Altman Z: 1.22
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CLXSignificantly Overvalued (-203.1%)

Margin of Safety

-203.1%

Fair Value

$41.55

Current Price

$104.76

$63.21 premium

UndervaluedFair: $41.55Overvalued
KVUEUndervalued (+1.3%)

Margin of Safety

+1.3%

Fair Value

$18.79

Current Price

$17.66

$1.13 discount

UndervaluedFair: $18.79Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CLX2 strengths · Avg: 9.0/10
Return on EquityProfitability
98.7%10/10

Every $100 of equity generates 99 in profit

P/E RatioValuation
17.1x8/10

Attractively priced relative to earnings

KVUE0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CLX3 concerns · Avg: 2.7/10
PEG RatioValuation
2.174/10

Expensive relative to growth rate

Revenue GrowthGrowth
-0.8%2/10

Revenue declined 0.8%

EPS GrowthGrowth
-16.2%2/10

Earnings declined 16.2%

KVUE3 concerns · Avg: 3.0/10
Revenue GrowthGrowth
3.2%4/10

3.2% revenue growth

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.222/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CLX

The strongest argument for CLX centers on Return on Equity, P/E Ratio.

Bull Case : KVUE

PEG of 1.49 suggests the stock is reasonably priced for its growth.

Bear Case : CLX

The primary concerns for CLX are PEG Ratio, Revenue Growth, EPS Growth.

Bear Case : KVUE

The primary concerns for KVUE are Revenue Growth, Piotroski F-Score, Altman Z-Score.

Key Dynamics to Monitor

CLX profiles as a declining stock while KVUE is a value play — different risk/reward profiles.

CLX carries more volatility with a beta of 0.57 — expect wider price swings.

KVUE is growing revenue faster at 3.2% — sustainability is the question.

KVUE generates stronger free cash flow (744M), providing more financial flexibility.

Bottom Line

KVUE scores higher overall (58/100 vs 51/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

The Clorox Company

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

The Clorox Company, based in Oakland, California, is an American global manufacturer and marketer of consumer and professional products.

Kenvue Inc.

CONSUMER DEFENSIVE · HOUSEHOLD & PERSONAL PRODUCTS · USA

Kenvue Inc. is a consumer health company globally.

Visit Website →

Want to dig deeper into these stocks?